Eurobio Scientific signe un accord définitif en vue de l'acquisition de la division « Lab Products » de CareDx dédiée à la transplantation
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Qualifacts announced it will acquire MethodOne, a controlled-medication dispensing software provider purpose-built for opioid treatment programs (OTPs) and substance use disorder (SUD) providers. The deal is designed to integrate MethodOne’s medication dispensing and inventory management capabilities into Qualifacts’ behavioral health EHR platforms.
Qualifacts positions the combined offering as a unified solution for MAT and MOUD dispensing, aiming to reduce compliance and billing burden for OTPs that operate under overlapping DEA, SAMHSA, and state oversight. The company also cites a shift from office-based opioid treatment models to OTPs, increasing demand for an integrated clinical plus dispensing platform.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Eurobio Scientific→CareDx Lab Products division
Apr 16, 2026
Quvara Medical→Becton Dickinson
Apr 15, 2026
Parkview Health→Witham Health Services
Apr 15, 2026
Surgery Partners→Preferred Vascular Group
Apr 15, 2026
Sectra→Oxipit
Apr 15, 2026